MedinCell S.A.
MDCLF · OTC
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $187,708 | $182,386 | $187,645 |
| - Cash | $22,849 | $59,040 | $31,636 | $19,460 |
| + Debt | $61,776 | $58,756 | $59,605 | $58,961 |
| Enterprise Value | – | $187,424 | $210,355 | $227,146 |
| Revenue | $13,621 | $16,106 | $9,435 | $3,765 |
| % Growth | -15.4% | 70.7% | 150.6% | – |
| Gross Profit | $0 | $16,106 | $9,435 | $3,436 |
| % Margin | 0% | 100% | 100% | 91.3% |
| EBITDA | -$17,363 | -$3,941 | -$7,259 | -$11,551 |
| % Margin | -127.5% | -24.5% | -76.9% | -306.8% |
| Net Income | -$18,867 | -$3,870 | -$14,568 | -$16,880 |
| % Margin | -138.5% | -24% | -154.4% | -448.3% |
| EPS Diluted | -0.57 | -0.13 | -0.5 | -0.58 |
| % Growth | -338.5% | 74% | 13.8% | – |
| Operating Cash Flow | -$16,725 | -$3,078 | $21,559 | -$163 |
| Capital Expenditures | -$270 | -$597 | -$195 | -$172 |
| Free Cash Flow | -$16,995 | -$3,675 | $21,364 | -$335 |